Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ILC Therapeutics Announces Successful Completion of £3.5m Funding Round
ILC Therapeutics, a UK-based biotechnology company and pioneer in the discovery and development of a […]
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease
NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG;OTCQX: RHHBY) today announced a […]
LloydsPharmacy Expands Digital Healthcare Offering with New VideoGP Service
LloydsPharmacy has today (Wednesday 25th August) launched a VideoGP app that provides access to an experienced […]
Swiss Medtech Bloom Diagnostics Company Opens its First Flagship Store in Zurich
Swiss medtech company Bloom Diagnostics has, today, opened its first-ever flagship store at a busy […]
Additional £5.4 Billion for NHS Covid Response Over Next Six Months
The NHS will receive an extra £5.4 billion over the next six months to support […]
Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain
Local family cord blood bank Cryoviva Singapore is continuing with its rapid geographic growth plans […]
Enesi Pharma Appoints Elizabeth Eagling-Vose, MBA, as Senior Vice President, Operations
Enesi Pharma Ltd (“Enesi”), an innovative biotechnology company developing next-generation vaccination products, targeting infectious diseases […]
Bupa UK Insurance Agrees New Three-year Contract with Circle Health Group, Owner of BMI
Bupa UK Insurance, the leading private healthcare insurance provider and Circle Health Group, Britain’s largest […]
Abbott Expands with Acquisition of Walk Vascular, LLC
Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with […]
XNK Therapeutics Appoints Markus Thor as Chief Business Officer
XNK Therapeutics AB today announced the appointment of Markus Thor as Chief Business Officer, effective September 6th. He […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more